According to FDA prescribing information, these include nausea (occurring in 1544% of patients depending on the agent and dose), vomiting, diarrhea, constipation, and abdominal pain
Tachycardia Most patients see at least some heart rate increase on GLP-1 drugs, but some studies have shown significant jumps into the range of tachycardia
The best place to inject semaglutide GLP-1 is typically in the fatty tissue just under the skin, also known as the subcutaneous tissue
While this can be beneficial for those with diabetes, recent studies have shown agonist medications like GLP 1 can cause serious adverse effects, especially in those who are not diabetic
But, a big question arises: could these drugs affect our mental health
Previous Struggles: Patients who have tried diet and exercise alone but have been unable to sustain significant weight loss